X4 Pharmaceuticals to Participate in Guggenheim's Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) largest shareholders are individual investors with 52% ownership, institutions own 31% [Yahoo! Finance]
Catalio-Backed Rhapsogen Names Renato Skerlj, Ph.D., Chief Executive Officer [Yahoo! Finance]